These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 38761314)

  • 1. HDAC inhibitors as a potential therapy for chemotherapy-induced neuropathic pain.
    Manengu C; Zhu CH; Zhang GD; Tian MM; Lan XB; Tao LJ; Ma L; Liu Y; Yu JQ; Liu N
    Inflammopharmacology; 2024 May; ():. PubMed ID: 38761314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase as emerging pharmacological therapeutic target for neuropathic pain: From epigenetic to selective drugs.
    Zhang W; Jiao B; Yu S; Zhang C; Zhang K; Liu B; Zhang X
    CNS Neurosci Ther; 2024 May; 30(5):e14745. PubMed ID: 38715326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined inhibition of histone deacetylases and BET family proteins as epigenetic therapy for nerve injury-induced neuropathic pain.
    Borgonetti V; Galeotti N
    Pharmacol Res; 2021 Mar; 165():105431. PubMed ID: 33529752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual HDAC/BRD4 Inhibitors Relieves Neuropathic Pain by Attenuating Inflammatory Response in Microglia After Spared Nerve Injury.
    Borgonetti V; Meacci E; Pierucci F; Romanelli MN; Galeotti N
    Neurotherapeutics; 2022 Sep; 19(5):1634-1648. PubMed ID: 35501470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zingiberene, a non-zinc-binding class I HDAC inhibitor: A novel strategy for the management of neuropathic pain.
    Borgonetti V; Governa P; Manetti F; Galeotti N
    Phytomedicine; 2023 Mar; 111():154670. PubMed ID: 36681053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual BET/HDAC inhibition to relieve neuropathic pain: Recent advances, perspectives, and future opportunities.
    Romanelli MN; Borgonetti V; Galeotti N
    Pharmacol Res; 2021 Nov; 173():105901. PubMed ID: 34547384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HDAC inhibitors attenuate the development of hypersensitivity in models of neuropathic pain.
    Denk F; Huang W; Sidders B; Bithell A; Crow M; Grist J; Sharma S; Ziemek D; Rice ASC; Buckley NJ; McMahon SB
    Pain; 2013 Sep; 154(9):1668-1679. PubMed ID: 23693161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy.
    Fumagalli G; Monza L; Cavaletti G; Rigolio R; Meregalli C
    Front Immunol; 2020; 11():626687. PubMed ID: 33613570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase inhibition inhibits brachial plexus avulsion-induced neuropathic pain.
    Zhao Y; Wu T
    Muscle Nerve; 2018 Sep; 58(3):434-440. PubMed ID: 29742796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase inhibitor-induced emergence of synaptic δ-opioid receptors and behavioral antinociception in persistent neuropathic pain.
    Tao W; Zhou W; Wang Y; Sun T; Wang H; Zhang Z; Jin Y
    Neuroscience; 2016 Dec; 339():54-63. PubMed ID: 27646288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of histone deacetylase inhibitor JNJ-26481585 in pain.
    Capasso KE; Manners MT; Quershi RA; Tian Y; Gao R; Hu H; Barrett JE; Sacan A; Ajit SK
    J Mol Neurosci; 2015 Mar; 55(3):570-8. PubMed ID: 25085711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase inhibitors relieve morphine resistance in neuropathic pain after peripheral nerve injury.
    Uchida H; Matsushita Y; Araki K; Mukae T; Ueda H
    J Pharmacol Sci; 2015 Aug; 128(4):208-11. PubMed ID: 26318673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF-A/VEGFR-1 signalling and chemotherapy-induced neuropathic pain: therapeutic potential of a novel anti-VEGFR-1 monoclonal antibody.
    Micheli L; Parisio C; Lucarini E; Vona A; Toti A; Pacini A; Mello T; Boccella S; Ricciardi F; Maione S; Graziani G; Lacal PM; Failli P; Ghelardini C; Di Cesare Mannelli L
    J Exp Clin Cancer Res; 2021 Oct; 40(1):320. PubMed ID: 34649573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcitonin gene-related peptide induces the histone H3 lysine 9 acetylation in astrocytes associated with neuroinflammation in rats with neuropathic pain.
    Sun C; An Q; Li R; Chen S; Gu X; An S; Wang Z
    CNS Neurosci Ther; 2021 Nov; 27(11):1409-1424. PubMed ID: 34397151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDAC inhibitors restore C-fibre sensitivity in experimental neuropathic pain model.
    Matsushita Y; Araki K; Omotuyi Oi; Mukae T; Ueda H
    Br J Pharmacol; 2013 Nov; 170(5):991-8. PubMed ID: 24032674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal neuroimmune activation is independent of T-cell infiltration and attenuated by A3 adenosine receptor agonists in a model of oxaliplatin-induced peripheral neuropathy.
    Janes K; Wahlman C; Little JW; Doyle T; Tosh DK; Jacobson KA; Salvemini D
    Brain Behav Immun; 2015 Feb; 44():91-9. PubMed ID: 25220279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SAFit2 reduces neuroinflammation and ameliorates nerve injury-induced neuropathic pain.
    Wedel S; Mathoor P; Rauh O; Heymann T; Ciotu CI; Fuhrmann DC; Fischer MJM; Weigert A; de Bruin N; Hausch F; Geisslinger G; Sisignano M
    J Neuroinflammation; 2022 Oct; 19(1):254. PubMed ID: 36217203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproic acid mitigates spinal nerve ligation-induced neuropathic pain in rats by modulating microglial function and inhibiting neuroinflammatory response.
    Guo A; Li J; Luo L; Chen C; Lu Q; Ke J; Feng X
    Int Immunopharmacol; 2021 Mar; 92():107332. PubMed ID: 33421931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The etiological changes of acetylation in peripheral nerve injury-induced neuropathic hypersensitivity.
    Wang X; Shen X; Xu Y; Xu S; Xia F; Zhu B; Liu Y; Wang W; Wu H; Wang F
    Mol Pain; 2018; 14():1744806918798408. PubMed ID: 30105933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Class I HDAC Inhibitor, MS-275, Prevents Oxaliplatin-Induced Chronic Neuropathy and Potentiates Its Antiproliferative Activity in Mice.
    Lamoine S; Cumenal M; Barriere DA; Pereira V; Fereyrolles M; Prival L; Barbier J; Boudieu L; Brasset E; Bertin B; Renaud Y; Miot-Noirault E; Civiale MA; Balayssac D; Aissouni Y; Eschalier A; Busserolles J
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.